Shanghai Kechow Pharma, Inc.
PrivateLast Round
Series D
Sep 1, 2023
Total Funding Raised
$75.65M
Company Overview
Shanghai Kechow Pharma, Inc. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series D round in September 2023.
Shanghai Kechow Pharma, Inc. is a pharmaceutical company that integrates drug discovery, clinical development, and sales of new anti-cancer drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Kechow Pharma, Inc. Comparables
Compare Shanghai Kechow Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ABM Therapeutics | 76% | |
| Dizal Pharmaceutical | 74% | |
| Zai Lab Limited | 74% |
For institutional investors. Book with your work email.
Shanghai Kechow Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 1, 2023 | ||||
| Series C Extension | Jul 1, 2022 | ||||
| Series C Extension | Nov 1, 2021 | ||||
| Series C | Dec 13, 2019 | ||||
| Series B | Jul 1, 2018 | ||||
Series A | Feb 1, 2016 |
For institutional investors. Book with your work email.
Shanghai Kechow Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YuanBio Venture Capital | Series A |
| DT Capital Partners | Series D |
| Grains Valley Venture Capital | Series A |
| 5Y Capital | Angel |
| China Merchants Capital | Series C Extension |
| SDIC Venture Capital | Series B |
| 荷塘创投 | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 2108% MoM, from 53 to 1.2K.
- Jun 15, 2026
Open roles increased from 0 to 7, representing 175% of headcount.
For institutional investors. Book with your work email.
Shanghai Kechow Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Kechow Pharma, Inc.'s valuation, stock price, and market status.
Is Shanghai Kechow Pharma, Inc. a public or private company?
Shanghai Kechow Pharma, Inc. is a private company.
What is the current stock price of Shanghai Kechow Pharma, Inc.?
Shanghai Kechow Pharma, Inc. is a private company, so its shares have no public market price. Caplight tracks Shanghai Kechow Pharma, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Kechow Pharma, Inc. worth (valuation)?
Valuation information for Shanghai Kechow Pharma, Inc. is not publicly available.
Can I buy Shanghai Kechow Pharma, Inc. stock?
Shanghai Kechow Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Kechow Pharma, Inc.'s last funding round?
Shanghai Kechow Pharma, Inc.'s most recent funding round was Series D on September 1, 2023.
Who are the main investors in Shanghai Kechow Pharma, Inc.?
Key investors in Shanghai Kechow Pharma, Inc. include 5Y Capital, China Merchants Capital, Lilly Asia Ventures, Decheng Capital.
Will Shanghai Kechow Pharma, Inc. IPO soon?
No public IPO plans have been announced for Shanghai Kechow Pharma, Inc..
How can I track Shanghai Kechow Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Kechow Pharma, Inc.'s shares on secondary markets.